| ■ 영문 제목 : Global Cancidas Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2108K201156 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 8월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 130 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (20명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 칸시다스의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (주사제, 테이블 제품, 기타)와 용도별 시장규모 (성인, 어린이) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 칸시다스 시장 점유율 - 지역별 칸시다스 시장규모 - 주요지역의 종류별 시장규모 (주사제, 테이블 제품, 기타) - 주요지역의 용도별 시장규모 (성인, 어린이) - 미주의 칸시다스 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 칸시다스 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 칸시다스 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 칸시다스 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 칸시다스 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) - 조사의 결과/결론 |
According to this latest study, the 2020 growth of Cancidas will have significant change from previous year. By the most conservative estimates of global Cancidas market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Cancidas market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Cancidas market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Injection Product
Table Product
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Adult
Child
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Fresenius SE & Co. KGaA (Fresenius Kabi)
Alvogen Inc.
Juno Pharmaceuticals (MDA Inc.)
Cipla Inc.
Merck & Co., Inc.
Athenex, Inc.
Sanofi S.A.
Sundent Pharmaceutical Co. Ltd.
Gland Pharma Limited
Sun Pharmaceutical Industries Ltd.
1 Scope of the Report 2 Executive Summary 3 Global Cancidas by Company 4 Cancidas by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global Cancidas Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. Cancidas Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Injection Product Table 3. Major Players of Table Product Table 4. Major Players of Others Table 5. Global Cancidas Sales by Type (2016-2021) & (K Units) Table 6. Global Cancidas Sales Market Share by Type (2016-2021) Table 7. Global Cancidas Revenue by Type (2016-2021) & ($ million) Table 8. Global Cancidas Revenue Market Share by Type (2016-2021) Table 9. Global Cancidas Sale Price by Type (2016-2021) Table 10. Global Cancidas Sales by Application (2016-2021) & (K Units) Table 11. Global Cancidas Sales Market Share by Application (2016-2021) Table 12. Global Cancidas Value by Application (2016-2021) Table 13. Global Cancidas Revenue Market Share by Application (2016-2021) Table 14. Global Cancidas Sale Price by Application (2016-2021) Table 15. Global Cancidas Sales by Company (2019-2021) & (K Units) Table 16. Global Cancidas Sales Market Share by Company (2019-2021) Table 17. Global Cancidas Revenue by Company (2019-2021) ($ Millions) Table 18. Global Cancidas Revenue Market Share by Company (2019-2021) Table 19. Global Cancidas Sale Price by Company (2019-2021) Table 20. Key Manufacturers Cancidas Producing Area Distribution and Sales Area Table 21. Players Cancidas Products Offered Table 22. Cancidas Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global Cancidas Sales by Region (2016-2021) (K Units) Table 26. Global Cancidas Sales Market Share by Region (2016-2021) Table 27. Global Cancidas Revenue by Region (2016-2021) & ($ Millions) Table 28. Global Cancidas Revenue Market Share by Region (2016-2021) Table 29. Americas Cancidas Sales by Country (2016-2021) & (K Units) Table 30. Americas Cancidas Sales Market Share by Country (2016-2021) Table 31. Americas Cancidas Revenue by Country (2016-2021) & ($ Millions) Table 32. Americas Cancidas Revenue Market Share by Country (2016-2021) Table 33. Americas Cancidas Sales by Type (2016-2021) & (K Units) Table 34. Americas Cancidas Sales Market Share by Type (2016-2021) Table 35. Americas Cancidas Sales by Application (2016-2021) & (K Units) Table 36. Americas Cancidas Sales Market Share by Application (2016-2021) Table 37. APAC Cancidas Sales by Region (2016-2021) & (K Units) Table 38. APAC Cancidas Sales Market Share by Region (2016-2021) Table 39. APAC Cancidas Revenue by Region (2016-2021) & ($ Millions) Table 40. APAC Cancidas Revenue Market Share by Region (2016-2021) Table 41. APAC Cancidas Sales by Type (2016-2021) & (K Units) Table 42. APAC Cancidas Sales Market Share by Type (2016-2021) Table 43. APAC Cancidas Sales by Application (2016-2021) & (K Units) Table 44. APAC Cancidas Sales Market Share by Application (2016-2021) Table 45. Europe Cancidas Sales by Country (2016-2021) & (K Units) Table 46. Europe Cancidas Sales Market Share by Country (2016-2021) Table 47. Europe Cancidas Revenue by Country (2016-2021) & ($ Millions) Table 48. Europe Cancidas Revenue Market Share by Country (2016-2021) Table 49. Europe Cancidas Sales by Type (2016-2021) & (K Units) Table 50. Europe Cancidas Sales Market Share by Type (2016-2021) Table 51. Europe Cancidas Sales by Application (2016-2021) & (K Units) Table 52. Europe Cancidas Sales Market Share by Application (2016-2021) Table 53. Middle East & Africa Cancidas Sales by Country (2016-2021) & (K Units) Table 54. Middle East & Africa Cancidas Sales Market Share by Country (2016-2021) Table 55. Middle East & Africa Cancidas Revenue by Country (2016-2021) & ($ Millions) Table 56. Middle East & Africa Cancidas Revenue Market Share by Country (2016-2021) Table 57. Middle East & Africa Cancidas Sales by Type (2016-2021) & (K Units) Table 58. Middle East & Africa Cancidas Sales Market Share by Type (2016-2021) Table 59. Middle East & Africa Cancidas Sales by Application (2016-2021) & (K Units) Table 60. Middle East & Africa Cancidas Sales Market Share by Application (2016-2021) Table 61. Global Cancidas Sales Forecast by Type (2021-2026) & (K Units) Table 62. Global Cancidas Sales Market Share Forecast by Type (2021-2026) Table 63. Global Cancidas Revenue Forecast by Type (2021-2026) & ($ Millions) Table 64. Global Cancidas Revenue Market Share Forecast by Type (2021-2026) Table 65. Global Cancidas Sales Forecast by Application (2021-2026) & (K Units) Table 66. Global Cancidas Sales Market Share Forecast by Application (2021-2026) Table 67. Global Cancidas Revenue Forecast by Application (2021-2026) & ($ Millions) Table 68. Global Cancidas Revenue Market Share Forecast by Application (2021-2026) Table 69. Fresenius SE & Co. KGaA (Fresenius Kabi) Basic Information, Cancidas Manufacturing Base, Sales Area and Its Competitors Table 70. Fresenius SE & Co. KGaA (Fresenius Kabi) Cancidas Product Offered Table 71. Fresenius SE & Co. KGaA (Fresenius Kabi) Cancidas Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 72. Fresenius SE & Co. KGaA (Fresenius Kabi) Main Business Table 73. Fresenius SE & Co. KGaA (Fresenius Kabi) Latest Developments Table 74. Alvogen Inc. Basic Information, Cancidas Manufacturing Base, Sales Area and Its Competitors Table 75. Alvogen Inc. Cancidas Product Offered Table 76. Alvogen Inc. Cancidas Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 77. Alvogen Inc. Main Business Table 78. Alvogen Inc. Latest Developments Table 79. Juno Pharmaceuticals (MDA Inc.) Basic Information, Cancidas Manufacturing Base, Sales Area and Its Competitors Table 80. Juno Pharmaceuticals (MDA Inc.) Cancidas Product Offered Table 81. Juno Pharmaceuticals (MDA Inc.) Cancidas Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 82. Juno Pharmaceuticals (MDA Inc.) Main Business Table 83. Juno Pharmaceuticals (MDA Inc.) Latest Developments Table 84. Cipla Inc. Basic Information, Cancidas Manufacturing Base, Sales Area and Its Competitors Table 85. Cipla Inc. Cancidas Product Offered Table 86. Cipla Inc. Cancidas Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 87. Cipla Inc. Main Business Table 88. Cipla Inc. Latest Developments Table 89. Merck & Co., Inc. Basic Information, Cancidas Manufacturing Base, Sales Area and Its Competitors Table 90. Merck & Co., Inc. Cancidas Product Offered Table 91. Merck & Co., Inc. Cancidas Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 92. Merck & Co., Inc. Main Business Table 93. Merck & Co., Inc. Latest Developments Table 94. Athenex, Inc. Basic Information, Cancidas Manufacturing Base, Sales Area and Its Competitors Table 95. Athenex, Inc. Cancidas Product Offered Table 96. Athenex, Inc. Cancidas Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 97. Athenex, Inc. Main Business Table 98. Athenex, Inc. Latest Developments Table 99. Sanofi S.A. Basic Information, Cancidas Manufacturing Base, Sales Area and Its Competitors Table 100. Sanofi S.A. Cancidas Product Offered Table 101. Sanofi S.A. Cancidas Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 102. Sanofi S.A. Main Business Table 103. Sanofi S.A. Latest Developments Table 104. Sundent Pharmaceutical Co. Ltd. Basic Information, Cancidas Manufacturing Base, Sales Area and Its Competitors Table 105. Sundent Pharmaceutical Co. Ltd. Cancidas Product Offered Table 106. Sundent Pharmaceutical Co. Ltd. Cancidas Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 107. Sundent Pharmaceutical Co. Ltd. Main Business Table 108. Sundent Pharmaceutical Co. Ltd. Latest Developments Table 109. Gland Pharma Limited Basic Information, Cancidas Manufacturing Base, Sales Area and Its Competitors Table 110. Gland Pharma Limited Cancidas Product Offered Table 111. Gland Pharma Limited Cancidas Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 112. Gland Pharma Limited Main Business Table 113. Gland Pharma Limited Latest Developments Table 114. Sun Pharmaceutical Industries Ltd. Basic Information, Cancidas Manufacturing Base, Sales Area and Its Competitors Table 115. Sun Pharmaceutical Industries Ltd. Cancidas Product Offered Table 116. Sun Pharmaceutical Industries Ltd. Cancidas Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 117. Sun Pharmaceutical Industries Ltd. Main Business Table 118. Sun Pharmaceutical Industries Ltd. Latest Developments List of Figures Figure 1. Picture of Cancidas Figure 2. Cancidas Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Cancidas Sales Growth Rate 2016-2026 (K Units) Figure 7. Global Cancidas Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Cancidas Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Injection Product Figure 10. Product Picture of Table Product Figure 11. Product Picture of Others Figure 12. Global Cancidas Sales Market Share by Type in 2020 Figure 13. Global Cancidas Revenue Market Share by Type (2016-2021) Figure 14. Cancidas Consumed in Adult Figure 15. Global Cancidas Market: Adult (2016-2021) & (K Units) Figure 16. Cancidas Consumed in Child Figure 17. Global Cancidas Market: Child (2016-2021) & (K Units) Figure 18. Global Cancidas Sales Market Share by Application (2016-2021) Figure 19. Global Cancidas Revenue Market Share by Application in 2020 Figure 20. Global Cancidas Revenue Market by Company in 2020 ($ Million) Figure 21. Global Cancidas Revenue Market Share by Company in 2020 Figure 22. Global Cancidas Sales Market Share by Regions (2016-2021) Figure 23. Global Cancidas Revenue Market Share by Region in 2020 Figure 24. Americas Cancidas Sales 2016-2021 (K Units) Figure 25. Americas Cancidas Revenue 2016-2021 ($ Millions) Figure 26. APAC Cancidas Sales 2016-2021 (K Units) Figure 27. APAC Cancidas Revenue 2016-2021 ($ Millions) Figure 28. Europe Cancidas Sales 2016-2021 (K Units) Figure 29. Europe Cancidas Revenue 2016-2021 ($ Millions) Figure 30. Middle East & Africa Cancidas Sales 2016-2021 (K Units) Figure 31. Middle East & Africa Cancidas Revenue 2016-2021 ($ Millions) Figure 32. Americas Cancidas Sales Market Share by Country in 2020 Figure 33. Americas Cancidas Revenue Market Share by Country in 2020 Figure 34. Americas Cancidas Sales Market Share by Type in 2020 Figure 35. Americas Cancidas Sales Market Share by Application in 2020 Figure 36. United States Cancidas Revenue Growth 2016-2021 ($ Millions) Figure 37. Canada Cancidas Revenue Growth 2016-2021 ($ Millions) Figure 38. Mexico Cancidas Revenue Growth 2016-2021 ($ Millions) Figure 39. Brazil Cancidas Revenue Growth 2016-2021 ($ Millions) Figure 40. APAC Cancidas Sales Market Share by Region in 2020 Figure 41. APAC Cancidas Revenue Market Share by Regions in 2020 Figure 42. APAC Cancidas Sales Market Share by Type in 2020 Figure 43. APAC Cancidas Sales Market Share by Application in 2020 Figure 44. China Cancidas Revenue Growth 2016-2021 ($ Millions) Figure 45. Japan Cancidas Revenue Growth 2016-2021 ($ Millions) Figure 46. Korea Cancidas Revenue Growth 2016-2021 ($ Millions) Figure 47. Southeast Asia Cancidas Revenue Growth 2016-2021 ($ Millions) Figure 48. India Cancidas Revenue Growth 2016-2021 ($ Millions) Figure 49. Australia Cancidas Revenue Growth 2016-2021 ($ Millions) Figure 50. Europe Cancidas Sales Market Share by Country in 2020 Figure 51. Europe Cancidas Revenue Market Share by Country in 2020 Figure 52. Europe Cancidas Sales Market Share by Type in 2020 Figure 53. Europe Cancidas Sales Market Share by Application in 2020 Figure 54. Germany Cancidas Revenue Growth 2016-2021 ($ Millions) Figure 55. France Cancidas Revenue Growth 2016-2021 ($ Millions) Figure 56. UK Cancidas Revenue Growth 2016-2021 ($ Millions) Figure 57. Italy Cancidas Revenue Growth 2016-2021 ($ Millions) Figure 58. Russia Cancidas Revenue Growth 2016-2021 ($ Millions) Figure 59. Middle East & Africa Cancidas Sales Market Share by Country in 2020 Figure 60. Middle East & Africa Cancidas Revenue Market Share by Country in 2020 Figure 61. Middle East & Africa Cancidas Sales Market Share by Type in 2020 Figure 62. Middle East & Africa Cancidas Sales Market Share by Application in 2020 Figure 63. Egypt Cancidas Revenue Growth 2016-2021 ($ Millions) Figure 64. South Africa Cancidas Revenue Growth 2016-2021 ($ Millions) Figure 65. Israel Cancidas Revenue Growth 2016-2021 ($ Millions) Figure 66. Turkey Cancidas Revenue Growth 2016-2021 ($ Millions) Figure 67. GCC Country Cancidas Revenue Growth 2016-2021 ($ Millions) Figure 68. Channels of Distribution Figure 69. Distributors Profiles |
| ※본 조사보고서 [세계의 칸시다스 시장예측 2021년-2026년] (코드 : LPI-2108K201156) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 칸시다스 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |